TFF PHARMACEUTICALS, INC. Notes Receivable, Fair Value Disclosure
TFF PHARMACEUTICALS, INC. had Notes Receivable, Fair Value Disclosure of $2.34 million as of 2024-03-31, per its 10-Q filed 2024-05-14.
Financial Statements › Notes
us-gaap:NotesReceivableFairValueDisclosure · last filed 2024-11-20
- 2024-03-31: Notes Receivable, Fair Value Disclosure $2.34M.
- 2023-12-31: Notes Receivable, Fair Value Disclosure $2.31M.
- 2023-09-30: Notes Receivable, Fair Value Disclosure $1.78M.
- 2022-12-31: Notes Receivable, Fair Value Disclosure $1.81M.
| Period end | Notes Receivable, Fair Value Disclosure |
|---|---|
| 2024-03-31 | $2.34M 10-Q · filed 2024-05-14 |
| 2023-12-31 | $2.31M 10-Q · filed 2024-11-20 |
| 2023-09-30 | $1.78M 10-Q · filed 2023-11-14 |
| 2022-12-31 | $1.81M 10-K · filed 2024-03-28 |